Kellie Benn - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Kellie Benn's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Kellie Benn
Verified
Vice President of Content, BioNews Services
Newport News
Beats
cultural history religion in society, opinion cultural diversity, Dance, Politics, the human senses point-of-view
Real-estate, law-related, scientific topics.
Content
By Marta C. Figueiredo, Kellie Benn, Rick Jobus, Patricia Inacio| ALS News Today@ by Marta Figueiredo PhD | July 19, 2021 Share this article: Zerbor/shutterstock AB Science’s proposed measures to ensure patient safety in clinical trials of its experimental oral therapy masitinib were deemed sufficient by the French National Agency for Medicines and Health Products Safety (ANSM), and patient enrollment in the country may resume. The announcement comes less than two months after the company temporarily suspended recruitment and treatment in all masitinib trials, after a...
By Lisa Weber, Kellie Benn, Jessica Massengale| Scleroderma News@ “Did I take my pills?” I wonder as I hold three giant capsules. I stare at them and try to backtrack through my day, but I have no idea. All my mornings collide together. Now I’m faced with the choice between skipping my lifesaving medicine or taking an extra dose, which could prove risky. No matter how hard I try to be consistent with my routines, this dilemma becomes a recurring scenario.
By Marta C. Figueiredo, Kellie Benn, Rick Jobus, Patricia Inacio| ALS News Today@ by Marta Figueiredo PhD | July 19, 2021 Share this article: Zerbor/shutterstock AB Science’s proposed measures to ensure patient safety in clinical trials of its experimental oral therapy masitinib were deemed sufficient by the French National Agency for Medicines and Health Products Safety (ANSM), and patient enrollment in the country may resume. The announcement comes less than two months after the company temporarily suspended recruitment and treatment in all masitinib trials, after a...
Company Info
BioNews Services
Bionews, Inc. is a digital health solutions company based in Delaware, founded in 2013. It specializes in supporting rare disease communities through over 68 health media websites, which serve more than 500,000 registered members. The company is committed to authenticity, with over half of its team having personal experience with rare diseases as patients or caregivers. Bionews connects patients, caregivers, and healthcare stakeholders by providing trusted news, clinical updates, and community resources. Its services include digital media platforms that offer condition-specific content, community engagement through forums and advocacy resources, and content development featuring articles, podcasts, and videos. The company also tracks user engagement and provides analytics to support client campaigns. Bionews collaborates with biotech, life sciences, and healthcare companies to enhance marketing and patient engagement in the rare disease sector.
'+1 800-936-1363
Founded: 2013